US-based National Enzyme Company has been granted a GMP Certificate
of manufacturing by the Australian Therapeutic Goods Administration
(TGA), allowing it to sell its enzyme and other herbal medicinal
products in Australia.
Mutual funds investing in health and biotechnology stocks have
provided little shelter from the bear market this year. Managers of
these funds say an aging population underpins demand for health
care products and services and the...
Australia's health authorities are urging all companies still
storing recalled products made by Pan Pharmaceuticals to
immediately supply information on when the stock is being
destroyed, following mistaken sales of some Pan...
Talks on solutions to combat the growing global incidence of
chronic disease continued this week when officials from the World
Health Organisation (WHO) met in Geneva with representatives of
some 30 food, beverage and producer associations.
Swedish biotech company Probi has signed a licence agreement with
the Australian probiotics supplier Health World, giving the
Australian firm the right to market products containing one of
Probi's patented bacteria on the Australian...
The Australian natural health industry is set to suffer as the
government warns people to avoid taking herbal and vitamin
supplements, following a major recall of products made by the
country's leading contract manufacturer.
The UK complementary medicines market has grown by almost 60 per
cent in the last five years to an estimated value of £130 million
(€187m), despite the impact of new legislation and negative
publicity regarding herbal remedies and...
Changing lifestyles are driving self-medication in Spain, according
to a new report. More and more people are buying treatments over
the counter, particularly to help stop smoking, to help sleeping
and for eye care.